Home › Crohn's Disease › Texas › Dallas

Pag-aaral pangklinika para sa Crohn's Disease sa Dallas, TX

Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Nagre-recruitPhase 2

Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

Baylor University Medical Center ( Site 5031), Dallas

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2/3

Baylor University Medical Center, Dallas
UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Nagre-recruitPhase 4

GI Alliance - Digestive Health Associates of Texas, Dallas

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

Standardized Microbiota Transplant Therapy in Crohn's Disease

Nagre-recruitPhase 2

UT Southwestern, Dallas

Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06631586

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Nagre-recruit

University of Texas Southwestern, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05230173

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

Baylor University Hospital, Dallas

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06456593

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Nagre-recruitPhase 2

Mirador Therapeutics Selected Site, Dallas

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.